Microbial cell factories · 2026
Efficient vitamin A production in Lipomyces starkeyi through metabolic engineering of the β-carotene and retinoid pathways.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kinoshita Akari, Sato Rikako, Higuchi Hibiki, Kobayashi Shunichi, Koketsu Kento, Watanabe Taro, Takaku Hiroaki
Аннотация
BACKGROUND: Vitamin A, an essential micronutrient, is critical for vision, immune function, and cellular differentiation. Traditional vitamin A production methods, primarily based on chemical synthesis, pose significant environmental challenges. Microbial fermentation offers a sustainable alternative, but microbial production of vitamin A has yet to match chemical synthesis in terms of yield and cost-effectiveness. Oleaginous yeasts, such as Lipomyces starkeyi, which can synthesize high levels of acetyl-CoA and lipids, represent promising platforms for producing high-value lipophilic compounds, such as vitamin A.
RESULTS: L. starkeyi was engineered for the first time to produce vitamin A by introducing key enzymes in the β-carotene and retinoid biosynthetic pathways. This approach included integrating genes encoding lycopene cyclase/phytoene synthase (McCarRP), phytoene desaturase (McCarB), and β-carotene 15,15'-dioxygenase (MbBlh). Further optimization of the mevalonate pathway enabled the production of over 600 mg/L vitamin A in a 3-L fed-batch fermentation. Fe2⁺ supplementation improved yield, while a two-phase culture system using dodecane and butylated hydroxytoluene enhanced vitamin A recovery, with over 90% recovered in the extracellular phase.
CONCLUSIONS: This study establishes L. starkeyi as a promising host for sustainable vitamin A production. Although significant improvements in yield were achieved, further optimization of pathway regulation and fermentation conditions is needed to reach economically competitive levels. These findings provide a foundation for developing L. starkeyi as a platform for large-scale production of vitamin A and other valuable terpenoids.
RESULTS: L. starkeyi was engineered for the first time to produce vitamin A by introducing key enzymes in the β-carotene and retinoid biosynthetic pathways. This approach included integrating genes encoding lycopene cyclase/phytoene synthase (McCarRP), phytoene desaturase (McCarB), and β-carotene 15,15'-dioxygenase (MbBlh). Further optimization of the mevalonate pathway enabled the production of over 600 mg/L vitamin A in a 3-L fed-batch fermentation. Fe2⁺ supplementation improved yield, while a two-phase culture system using dodecane and butylated hydroxytoluene enhanced vitamin A recovery, with over 90% recovered in the extracellular phase.
CONCLUSIONS: This study establishes L. starkeyi as a promising host for sustainable vitamin A production. Although significant improvements in yield were achieved, further optimization of pathway regulation and fermentation conditions is needed to reach economically competitive levels. These findings provide a foundation for developing L. starkeyi as a platform for large-scale production of vitamin A and other valuable terpenoids.